Consistent with this, GPX4 inhibition induces ferroptosis in AML cells both in vitro and in vivo, evidenced by characteristic mitochondrial lipid peroxidation, highlighting GPX4 as a potential therapeutic target [83]. This evidence concerns the gene GPX4 and acute myeloid leukemia.